Gut microbes affect cognition during ageing
By Yi‑Ting Cheng & Sarkis K. Mazmanian — 11 March 2026
Summary
New work highlighted by Cox et al. (reported in Nature) shows that, in mice, changes in the gut microbiome during ageing contribute to declines in learning and memory. The mechanism appears to involve altered gut–brain signalling — described as intestinal interoceptive dysfunction — linking microbial shifts in the gut to cognitive changes in the brain.
Key Points
- Ageing in mice is associated with changes in gut microbial composition that correlate with cognitive decline.
- Cox et al. provide experimental evidence that altered gut-to-brain signalling (intestinal interoception) drives age-related impairments in learning and memory.
- The finding positions the gut microbiome as a potential modifiable contributor to cognitive ageing.
- Results come from mouse models; translation to humans will require further validation and clinical studies.
- The study expands the microbiome–brain axis literature and suggests new targets for interventions to preserve cognitive function with age.
Content summary
Progressive declines in learning and memory are a normal part of ageing, and more severe deterioration is seen in conditions such as dementia. Cox et al.’s paper links those cognitive changes in mice to shifts in gut-microbe communities that disrupt signalling between the gut and the brain.
The work demonstrates mechanistic connections — at least in rodents — between intestinal sensory signalling (interoception) and brain processes underpinning memory. While this strengthens the case for microbiome-influenced brain ageing, the authors and commentators note that human relevance and therapeutic translation remain open questions.
Context and relevance
This study sits at the intersection of microbiology, neuroscience and ageing research. It adds experimental weight to the growing idea that the gut microbiome can influence brain health across the lifespan, not just in early development or acute disease. For researchers and clinicians, it highlights the gut–brain axis as a possible target for interventions designed to slow cognitive ageing; for industry and biotech, it flags opportunities (and the need for rigorous human trials) in microbiome-based therapies.
Why should I read this?
Quick and blunt: if you care about why memory gets worse as we get older, this is interesting. The paper gives a neat, experimentally backed link between microbes in the gut and brain function in ageing mice — so it's worth a skim if you follow neuroscience, microbiome science or ageing research (and definitely worth a deeper read if you work in those fields).